Submit Covaxin Phase 3 efficacy data: SEC

The Subject Expert Committee (SEC), which advises the Indian drug regulator Drugs Controller General of India (DCGI), has asked Bharat Biotech to submit efficacy and safety data from its ongoing Phase III Covaxin trials before seeking approval for conducting trials on children.

from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://ift.tt/3ktHHC9

Comments

Post a Comment

Popular posts from this blog

Hyd rain: Getting rid of flood water proves costly

Image
Over a week after heavy rains lashed the city and flooded several areas, colonies in different parts of the city are still struggling to get rid of the muddy water and sewage that inundated their homes by spending hundreds of rupees every day. from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://ift.tt/35zbEK7
Read more